Tag Archives: 5-Fluorouracil

New Hope for Patients with Advanced Metastatic Colorectal Cancer Patients

Colorectal cancer is the fourth most common cancer in men and women with nearly 500,000 deaths due to colorectal cancer every year.  When detected early at localized stage I, the 5-year survival rate can reach 90%. At this stage, surgical … Continue reading

Posted in Cancer, Colorectal cancer | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

New Treatment for Colorectal Cancer Patients with Liver Metastases

In the past, bevacizumab (Avastin) plus FOLFOX (leucovorin, 5-fluorouracil, and oxaliplatin) is the mainstay treatment for colorectal cancer patients with metastases (Stage IV).  Even though the response rate of this regimen is impressive, less than 10% of Stage IV colorectal cancer … Continue reading

Posted in Cancer, Colorectal cancer | Tagged , , , , , , , , , , | Leave a comment

A New Treatment Option for patients with Gastric Cancer

 Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related deaths worldwide.  Previous study has found that patients with operable disease have a 5-year survival rate of 36%.  In patients with advanced or … Continue reading

Posted in Cancer, Gastric Cancer | Tagged , , , , , , , , , | Leave a comment

Standard Chemo Better Than Oral Capecitabine in Elderly Breast Cancer

Most elderly breast cancer patients would prefer oral chemotherapy such as capecitabine (Xeloda, Roche) over intravenous chemotherapy due to the convenience.  However, a clinical trial conducted in elderly women with early-stage breast cancer has found that standard adjuvant combination chemotherapy … Continue reading

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , | Leave a comment